Showing results (311-320 of 653) with videos related to

Sort By:
Pageof 66
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast CancerArgun Akcakanat, Xiaofeng Zheng, Christian X Cruz Pico, et al.
Hepatobiliary Surgery and Nutrition|January 14, 2020
Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patientsPingzhou Yang, Milind Javle, Fei Pang, et al.
JCO Precision Oncology|September 11, 2020
Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated MalignanciesVivek Subbiah, Shiraj Sen, Kenneth R Hess, et al.
Cancer|June 28, 2005
Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocolChandrajit P Raut, Kelly K Hunt, Jeri S Akins, et al.
Annals of Diagnostic Pathology|September 11, 2014
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancerJane H Zhou, Daniel Rosen, Andreas Andreou, et al.
Cancer Discovery|December 8, 2021
Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket StudyClaire F Friedman, John D Hainsworth, Razelle Kurzrock, et al.
Cancer|June 28, 2012
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancerAna M Gonzalez-Angulo, Huiqin Chen, Meghan S Karuturi, et al.
The Oncologist|March 26, 2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitisFunda Meric-Bernstam, Aditya Bardia, Paolo Bossi, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceSiqing Fu, Naiyi Shi, Jennifer Wheler, et al.
Scientific Reports|August 2, 2025
RNA sequencing and immunohistochemistry jointly improve tumor biomarker interpretationVladimir Kushnarev, Danil Stupichev, Suren Davitavyan, et al.
Pageof 66